has decided to embark on the path of fine-tuning and developing rhNGF in its formulation for clinical use, at its own biotech facility in L’Aquila. and in Naples, where there are the laboratories of Drug Discovery and Technology Formulation, within a long-term collaboration with CNR. Italian excellence: the Dompé Hub in L’Aquila. Dompé has concentrated its manufacturing and research and development activities at its L’Aquila hub.

Author: Fetaxe Mir
Country: Malta
Language: English (Spanish)
Genre: Automotive
Published (Last): 28 March 2004
Pages: 399
PDF File Size: 20.26 Mb
ePub File Size: 20.78 Mb
ISBN: 789-7-19737-256-9
Downloads: 74892
Price: Free* [*Free Regsitration Required]
Uploader: Voodookus

Sorry, your blog cannot share posts by email.

Post was not sent – check your email addresses! This site uses third party cookies. In humans, NGF is naturally produced as pre-pro-peptide, secreted into the endoplasmic reticulum and cleaved by furin protease. The hub, which operates forumlation compliance with GMP rules, is authorised to manufacture products using recombinant DNA technology, i.

In this phase the fermentation volume grows from a few litres initially up to litres, and in the end the proNGF gene is activated and begins the real protein production.

By continuing to use this web site, you are consenting to the use of cookies.

L’Aquila hub

Biotechnological production comprises one upstream phase the production of the active principle from biological material and one downstream phase purification. Home Research and Innovation Our research. Home Research and Innovation An Italian excellence.

In the first study, only patients with the disease in one eye were enrolled, while in the second study, patients with the domoe in both eyes were treated in both eyes bilaterally. Do you want to be redirected to the mobile version? Buchi Reddy on National award to Anthony Melv….

In the turnover was million is focused both on the development of pharmaceuticals for therapeutic needs as yet unfulfilled, in the areas of ophthalmology, oncology, diabetes and organ transplant, as well as in the creation of innovative industrialisation processes of these. Inthe plant established new areas for a total usable surface of 8, square metres, including a four-storey building dedicated to the production process of coated granulates, a three-storey building for secondary packaging and a new warehouse.

Current activities are concentrated in several sectors: By continuing to use this web site, you are consenting to the use of cookies. Cenegermin contains amino acids and has a relative molecular mass of 13, Daltons and the following molecular formula: The protein—in this case Nerve Growth Factor, NGF —is produced using a living organism the bacterium Escherichia Coli of which the entire genome and the complex of biological interactions is known in detail.

Food and Drug Administration today approved the first drug, Oxervate cenegerminfor the treatment of neurotrophic keratitis, a rare disease affecting the cornea the clear layer that covers the colored portion of the front of the eye.

We suggest you to update it for free by following one of the these links, choosing the browser you prefer: Discovered in the s by Nobel Prize winner Rita Levi Montalcini, NGF belongs to the neurotrophins, a family of proteins that can play a crucial role in regulating the survival, development and functions of neurons, both at a central and peripheral level.

Regarded as among the world’s foremost experts on corneal diseases, he was appointed Adjunct Assistant Professor of Biology at Temple University of Philadelphia.

Radhakrishnan and Dr B. He has earned a PhD in the research of the regenerative role of NGF in ocular degenerative syndromes. This technology makes it possible to create new generation granulates where the coating of the granule allows the drug to be taken without the traditional dilution with water.

We suggest you to update it for free by following one of the these links, choosing the browser you prefer: The application of Smart Factory concepts in the pharma context, in fact, is accompanied by certain peculiarities linked to qualitative and regulatory aspects. We suggest you to update it for free by following one of the these links, choosing the browser you prefer: Cenegermin is a human beta-nerve growth factor beta-ngf – – peptide non-covalent dimer produced in escherichia coli.

The production of liquids refers to the two lines of formulation and packaging known as small and large volume.

Projects using Artificial Intelligence techniques Neural Networks, Fuzzy Logic are also under way at the facility for analysing and optimizing certain dompr processes. In the downstream process the proNGF is first checked for its correct three-dimensional structure folding phase and then purified. At this point, the bacterial cells are separated from the cultivation broth, concentrated and recovered through a continuous centrifuge in order to separate the cells from the other residual organic material of the fermentation.


You are going to leave this site. The division works in close connection with the scientific community to make safe drugs available to patients that can meet their therapeutic needs. One group was treated with Oxervate eye drops and the other group was treated with an eye drop without cenegermin. Finally, the results of our clinical studies are made available on public databases, such as the website www.

He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc. The intervention concerned the creation of new areasconsisting of a four-storey building dedicated to the production process of coated granules, a three-storey building for packaging and a new warehouse.

Our story | Dompé

Because of the significant innovation it introduces in the field and its potential to offer an effective response to the yet unmet need by reducing the risk of rejection in pancreatic islet transplantation an extremely rare conditionReparixin has been classified as an orphan drug by the FDA and EMA. Join 2, other followers. The proNGF has an additional protein chain pro that has the difficult task of assisting the correct folding of the protein.

Medical Affairs also handles requests made by healthcare professionals for scientific information about the products in our portfolio.

For information, including how to block the cookies, click here. By continuing to use this web site, you are consenting to the use of cookies. To achieve the ambitious goal of providing answers to health questions, the continual pursuit of excellence and the ability to work as a system are, in fact, critical. Accessing the website you have selected you will be subject to the terms of use of this last. This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor rhNGF eye drops solution compared to vehicle for inducing a complete healing of stage 2 persistent epithelial defect and 3 corneal ulcer neurotrophic keratitis.

Our research | Dompé

Several laboratories are up and running at CDMO, for analytical development and quality control, making it possible to conduct the most in-depth analyses in the biotechnology field. At its biotech plant, the company has specialised in the development of new processes and in the production of biotech products on an industrial scale. The chemokine CXCL8 plays a key role in the recruitment and activation of polymorphonuclear neutrophils in post-ischemia reperfusion injury after organ transplantion.

The loss of corneal sensation impairs corneal health causing progressive damage to the top layer of the cornea, including corneal thinning, ulceration, and perforation in severe cases. The activities being implemented included continuous control, through a monitoring network consisting of 1, elements SCADA that monitor the areas and production facilities.

Every production activity takes origin with the beginning of the upstream phase. Thanks to the skills encompassed by this organisation, the CDMO can offer applied answers to genetic cloning, including the expression of coded proteins, their purification and characterisation and the issuance of the GMP of the Drug Substance.

The BF unit works mainly in the field of ophthalmology with the aim of optimising the periocular and intraocular release of proteins, for the treatment of rare diseases.